These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19455607)

  • 1. Treatment of nonmuscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors.
    Madeb R; Golijanin D; Noyes K; Fisher S; Stephenson JJ; Long SR; Knopf J; Lyman GH; Messing EM
    Cancer; 2009 Jun; 115(12):2660-70. PubMed ID: 19455607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National practice patterns for immediate postoperative instillation of chemotherapy in nonmuscle invasive bladder cancer.
    Cookson MS; Chang SS; Oefelein MG; Gallagher JR; Schwartz B; Heap K
    J Urol; 2012 May; 187(5):1571-6. PubMed ID: 22425105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison Between Intravesical Chemotherapy Epirubicin and Mitomycin-C after TURB vs TURB Alone With Recurrence Rate of Non-Muscle Invasive Bladder Cancer: Meta-Analysis.
    Daryanto B; Purnomo AF; Seputra KP; Budaya TN
    Med Arch; 2022 Jun; 76(3):198-201. PubMed ID: 36200115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic and humanistic consequences of preventable bladder tumor recurrences in nonmuscle invasive bladder cancer cases.
    Lee CT; Barocas D; Globe DR; Oefelein MG; Colayco DC; Bruno A; O'Day K; Bramley T
    J Urol; 2012 Dec; 188(6):2114-9. PubMed ID: 23083857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?
    Sylvester RJ; Oosterlinck W; Holmang S; Sydes MR; Birtle A; Gudjonsson S; De Nunzio C; Okamura K; Kaasinen E; Solsona E; Ali-El-Dein B; Tatar CA; Inman BA; N'Dow J; Oddens JR; Babjuk M
    Eur Urol; 2016 Feb; 69(2):231-44. PubMed ID: 26091833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical chemotherapy prophylaxis in primary superficial bladder cancer: a meta-analysis of 3703 patients from 11 randomized trials.
    Huncharek M; Geschwind JF; Witherspoon B; McGarry R; Adcock D
    J Clin Epidemiol; 2000 Jul; 53(7):676-80. PubMed ID: 10941943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quality of care in patients with newly diagnosed bladder cancer: a prospective assessment in northern Germany].
    Reek C; Rink M; Bloch M; Hansen J; Chun FK; Schneider A; Busche J; Fisch M
    Urologe A; 2013 Jul; 52(7):986-90. PubMed ID: 23494336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
    Divrik RT; Yildirim U; Zorlu F; Ozen H
    J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M; McGarry R; Kupelnick B
    Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of European Organisation for Research and Treatment of Cancer score system for predication of immediate postoperative intravesical instillation of pirarubicin after transurethral resection of non-muscle invasive bladder cancer].
    Ding XL; Yang DL; Yan RP; Li ZP; Ye CW; He J; Yu L; He SC; Li HD
    Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):308-312. PubMed ID: 29730921
    [No Abstract]   [Full Text] [Related]  

  • 11. The HELENA study: Hexvix
    Gierth M; Breyer J; Zeman F; Fritsche HM; Cordes J; Karl A; Zaak D; Stenzl A; von Schmeling IK; Sommerhuber A; Zierer T; Burger M; Mayr R
    World J Urol; 2021 Oct; 39(10):3799-3805. PubMed ID: 34002265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials.
    Sylvester RJ; Oosterlinck W; van der Meijden AP
    J Urol; 2004 Jun; 171(6 Pt 1):2186-90, quiz 2435. PubMed ID: 15126782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative instillation therapy in superficial bladder cancer: is it effective regarding outcome and costs?
    Engel RP; Witjes JA
    Curr Opin Urol; 2009 Sep; 19(5):511-5. PubMed ID: 19553821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Single, immediate postoperative intra-vesical instillation (SI) compared to a single preoperative intra-vesical instillation of mitomycin C in non-muscle invasive bladder cancer (NMIBC). Phase II randomized trial].
    Breton J; Bernardeau S; Vallée M; Pillot P; Lebacle C; Delpech PO; Charles T; Biscans C; Vallat A; Pfister C; Irani J
    Prog Urol; 2021 Feb; 31(2):63-70. PubMed ID: 32891506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary on "economic and humanistic consequences of preventable bladder tumor recurrences in nonmuscle invasive bladder cancer cases." Lee CT, Barocas D, Globe DR, Oefelein MG, Colayco DC, Bruno A, O׳Day K, Bramley T, Department of Urology, University of Michigan, Ann Arbor, MI.: J Urol 2012;188(6):2114-9. [Epub 2012 Oct 18]. doi: 10.1016/j.juro.2012.08.005.
    Hollenbeck BK
    Urol Oncol; 2014 Oct; 32(7):1089. PubMed ID: 25443143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on early instillation of chemotherapy after transurethral resection of non-muscle-invasive bladder cancer.
    Oosterlinck W; Decaestecker K
    Expert Rev Anticancer Ther; 2018 May; 18(5):437-443. PubMed ID: 29528758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered?
    Babjuk M; Burger M; Compérat EM; Gontero P; Mostafid HA; Palou J; van Rhijn BWG; Rouprêt M; Shariat SF; Sylvester R; Zigeuner R; Capoun O; Cohen D; Dominguez-Escrig JL; Hernández V; Peyronnet B; Seisen T; Soukup V;
    Eur Urol Focus; 2018 Jul; 4(4):525-528. PubMed ID: 30061076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate post-transurethral resection of bladder tumor intravesical chemotherapy prevents non-muscle-invasive bladder cancer recurrences: an updated meta-analysis on 2548 patients and quality-of-evidence review.
    Perlis N; Zlotta AR; Beyene J; Finelli A; Fleshner NE; Kulkarni GS
    Eur Urol; 2013 Sep; 64(3):421-30. PubMed ID: 23830475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy with early intravesical instillation of adriamycin and long-term oral administration of 5-fluorouracil in superficial bladder cancer. The Kyushu University Urological Oncology Group.
    Ueda T; Naito S; Iguchi A; Sagiyama K; Osada Y; Ariyoshi A; Omoto T; Kumazawa J
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S31-6. PubMed ID: 1394813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate intravesical chemotherapy for low-grade bladder tumors in California: An underutilized practice and its impact on recurrence.
    Yap SA; Brunson A; Pugashetti N; Cress RD; Keegan THM; deVere White R; Wun T
    Urol Oncol; 2018 Nov; 36(11):498.e1-498.e7. PubMed ID: 30236855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.